Skip to main content

View full-text article in PMC

. 2022 Aug 8;12:915835. doi: 10.3389/fonc.2022.915835

Table 1.

Clinical characteristics of NSCLC patients.

		Dataset 1			Dataset 2
Characteristics		Response group	Non response group	p-value	Response group	Non response group	p-value
No. of patients		148	124	–	24	19	–
Gender	Male	81	69	3.843^a	22	15	4.987^a
Gender	Female	67	55	3.843^a	2	4	4.987^a
Age, median (SD), y		63.76 (11.30)	64.86 (10.65)	0.453^b	66.42 (9.86)	62.36 (14.58)	0.629^b
Smoking status	Ever	50	69	1.021^a	17	12	1.235^a
Smoking status	Never	98	55	1.021^a	7	7	1.235^a
Histological type	Adenocarcinoma	121	101	2.241^a	13	11	3.244^a
Histological type	Squamous cell carcinoma	27	23	2.241^a	11	8	3.244^a
TNM Stage	II	22	16	1.232^a	1	2	2.065^a
	III	118	103	0.863^a	20	15	0.983^a
	IV	8	5	1.528^a	3	2	1.024^a
Courses, median (SD)		4.56 ± 1.41	3.87 ± 2.04	0.002^b	3.87± 1.58	3.24± 1.06	0.688^a

^ap value of Chi-square test; ^bp value of two-sample t-test.

SD, standard deviation; TNM, tumor node metastasis classification.